SLC transporters are the cell's metabolic gates, controlling the movement of metabolites in and out of cells and organelles. Metabolite homeostasis is often dysregulated in disease, and human biology points to SLC transporters as avenues to treat many indications. Jnana is building the first drug discovery platform dedicated to SLC transporters. This proprietary chemistry and biology platform allows the company to rapidly and comprehensively address therapeutic targets across the greater the 400-member membrane protein family.
